Explore the Demand for Endoluminal Suturing Device in South Korea — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Demand for Endoluminal Suturing Device in South Korea

Key Insight

The demand for endoluminal suturing device in south korea is projected to grow from USD 2.4 million in 2026 to USD 4.1 million by 2036, at a CAGR of 5.4%. Needle-based Suturing Devices will dominate with a 62.0% market share, while bariatric will lead the application segment with a 45.0% share.

January 21, 2026

Anurag Sharma

250 Pages

Cite this Report

Demand for Endoluminal Suturing Device in South Korea

https://www.futuremarketinsights.com/reports/south-korea-endoluminal-suturing-device-market

License

Buy Now

Summary ToC Companies

Key Players

Apollo Endosurgery
Boston Scientific
Cook Group
EndoRobotics Co
Erbe Elektromedizin GmbH
Fujifilm Holdings
Medtronic plc
Sony Group
Ovesco Endoscopy AG
STERIS plc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Endoluminal Suturing Device in South Korea

Key Players

Similar Industry Reports